IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,894 | -39.6% | 3,101 | -33.3% | 0.00% | – |
| Q2 2023 | $42,901 | +47.3% | 4,648 | +119.3% | 0.00% | – |
| Q1 2023 | $29,116 | +1269.5% | 2,119 | +1595.2% | 0.00% | – |
| Q4 2022 | $2,126 | -76.4% | 125 | -69.4% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 409 | -2.9% | 0.00% | – |
| Q2 2022 | $7,000 | -97.7% | 421 | -96.2% | 0.00% | – |
| Q1 2022 | $300,000 | +160.9% | 11,225 | +186.4% | 0.00% | – |
| Q4 2021 | $115,000 | -78.4% | 3,920 | -51.6% | 0.00% | – |
| Q3 2021 | $533,000 | -68.5% | 8,101 | -60.2% | 0.00% | – |
| Q2 2021 | $1,692,000 | +67.0% | 20,336 | +53.9% | 0.00% | – |
| Q1 2021 | $1,013,000 | -46.9% | 13,216 | -38.8% | 0.00% | – |
| Q4 2020 | $1,907,000 | +239.9% | 21,596 | +183.9% | 0.00% | – |
| Q3 2020 | $561,000 | -27.7% | 7,606 | -28.5% | 0.00% | – |
| Q2 2020 | $776,000 | -14.3% | 10,640 | -34.1% | 0.00% | – |
| Q1 2020 | $906,000 | +815.2% | 16,143 | +518.0% | 0.00% | – |
| Q4 2019 | $99,000 | – | 2,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |